Allarity Therapeutics Inc ALLR:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:16 PM EDT
0.76quote price arrow down-0.0276 (-3.5003%)
Volume
4,468,402
Close
0.7885quote price arrow down-0.0075 (-0.9422%)
Volume
4,202,454
52 week range
0.71 - 315.92
Loading...
  • Open0.76
  • Day High0.8171
  • Day Low0.7298
  • Prev Close0.796
  • 52 Week High315.92
  • 52 Week High Date05/16/23
  • 52 Week Low0.71
  • 52 Week Low Date05/07/24

Key Stats

  • Market Cap1.882M
  • Shares Out2.39M
  • 10 Day Average Volume15.17M
  • Dividend-
  • Dividend Yield-
  • Beta0.22
  • YTD % Change-92.85

KEY STATS

  • Open0.76
  • Day High0.8171
  • Day Low0.7298
  • Prev Close0.796
  • 52 Week High315.92
  • 52 Week High Date05/16/23
  • 52 Week Low0.71
  • 52 Week Low Date05/07/24
  • Market Cap1.882M
  • Shares Out2.39M
  • 10 Day Average Volume15.17M
  • Dividend-
  • Dividend Yield-
  • Beta0.22
  • YTD % Change-92.85

RATIOS/PROFITABILITY

  • EPS (TTM)-71,402.80
  • P/E (TTM)-0.00
  • Fwd P/E (NTM)-0.30
  • EBITDA (TTM)-17.083M
  • ROE (TTM)-2,855.08%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-47.26%

EVENTS

  • Earnings Date05/21/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Allarity Therapeutics Inc

 

Profile

MORE
Allarity Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing personalized cancer treatments. The Company is focused on development of stenoparib, a poly-ADP-ribose polymerase/Tankyrase inhibitor for advanced ovarian cancer patients, using its DRP companion diagnostic for patient selection in the ongoing phase 2 clinical trial, NCT03878849. It has in-licensed the intellectual property rights to develop, use and market stenoparib. Its DRP...
Gerald McLaughlin
Independent Chairman of the Board
Thomas Jensen
Chief Executive Officer
Joan Brown
Interim Chief Financial Officer, Director - Financial Reporting
Address
24 School St., 2Nd Floor
Boston, MA
02108
United States

Top Peers

SYMBOLLASTCHG%CHG
BBLG
Bone Biologics Corp
2.30+0.40+21.05%
EVLO
Evelo Biosciences Inc
0.0505+0.0105+26.25%
PRFX
PainReform Ltd
0.854+0.034+4.1463%
SLRX
Salarius Pharmaceuticals Inc
0.4791-0.0109-2.2245%
DRMA
Dermata Therapeutics Inc
0.3356-0.0444-11.6842%